This inventor holds 31 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Pfizer Corporation, Abbott Laboratories Corporation, Tularik Limited. Active years: 1989-2006.
Location History:
- Deerfield, IL (US) (1989 - 1990)
- Groton, CT (US) (1990)
- New York, NY (US) (1994 - 1996)
- East Lyme, CT (US) (1989 - 1998)
- Burlingame, CA (US) (1997 - 2006)
Company Filing History:
14 out of 4,486Â 
7 out of 4,186Â 
7 out of 126Â 
Years Active: 1989-2006
Areas of Expertise:
Title: The Innovations of Terry J Rosen: A Profile
Introduction
Terry J Rosen is an accomplished inventor based in Burlingame, CA, renowned for his significant contributions to the field of pharmacology. With a robust portfolio of 31 patents, his work primarily focuses on novel medicinal compounds that hold promising potential for treating various diseases.
Latest Patents
Among his latest innovations is the development of pentafluorobenzenesulfonamides and their analogs. This invention encompasses methods and compositions that relate to novel pentafluorophenylsulfonamide derivatives. These compounds are identified for their pharmacological activities, particularly in treating serious health conditions such as atherosclerosis, hypercholesterolemia, cancer, vascular restenosis, microbial infections, and psoriasis. The compositions, which include compounds of a specific general formula, serve as lead compounds for further development as effective pharmacological agents.
Career Highlights
Terry J Rosen has built an impressive career, having worked with renowned pharmaceutical companies such as Pfizer Corporation and Abbott Laboratories. His tenure at these institutions has allowed him to engage in cutting-edge research and development, translating scientific discoveries into tangible therapeutic solutions.
Collaborations
In his professional journey, Terry has collaborated with notable individuals, including coworkers Julio Cesar Medina and David Louis Clark. These partnerships have helped foster innovative ideas and advancements in medicinal chemistry, enhancing the scope and impact of their collective research initiatives.
Conclusion
In summary, Terry J Rosen stands out as a key figure in the realm of pharmaceutical innovations. His extensive portfolio of patents and his collaborative efforts within leading pharmaceutical companies highlight his commitment to advancing medical science. As new research continues to emerge from his inventions, the potential for improved treatments and therapeutic agents remains optimistic and exciting.